Esomeprazole Magnesium Capsule, Delayed Release
Product Images NDC 50090-7360

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 50090-7360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)

Esomeprazolemagnesiumfigure1 (Esomeprazolemagnesiumfigure1)
Chemical structure of Esomeprazole Magnesium, showing its molecular arrangement including magnesium ion complexed with the active molecule.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph showing the percent maintained over a 6-month period for Esomeprazole Magnesium Delayed-Release Capsules at 40 mg, 25 mg, and 10 mg doses versus placebo. The y-axis represents percent maintained (0-100%), and the x-axis represents months (0-6). Four lines illustrate the maintenance rates for each dosage and placebo, with higher doses showing higher percentages maintained over time.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
A line graph showing percent maintained over six months for Esomeprazole Magnesium delayed-release capsules at 40 mg, 20 mg, and 10 mg dosages compared with placebo. The graph includes four distinct lines representing each group, with 40 mg maintaining the highest percent over time and placebo the lowest.*
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
A line graph showing the percentage of patients symptom-free over a 28-day Diary Day period. Three treatments are compared: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. The 40 mg dosage generally shows the highest percentage of symptom-free patients, followed by 20 mg and placebo, with values fluctuating over the days.*
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
A line graph displaying the percent of patients symptom-free over 28 diary days. It compares three groups: Esomeprazole Magnesium Delayed-Release Capsules 40 mg, 20 mg, and placebo. Both dosages show higher percentages of symptom-free patients than placebo throughout the study period.*
FDA Label Image

Label Image (Lbl500907360)

Label Image (Lbl500907360)
Esomeprazole Magnesium 40 mg delayed-release capsules packaging label by A-S Medication Solutions. The label indicates each capsule contains 40 mg of Esomeprazole magnesium (as 46.5 mg of Esomeprazole magnesium trihydrate USP). The package contains 90 capsules and includes storage instructions to keep between 68 to 77 degrees Fahrenheit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.